Author:
Rodríguez Weber Federico, Díaz Greene Enrique, Ahumada Zavala Silvia Nayeli,Ortega Chavarría María José
Reference28 articles.
1. Marrón-Peña M. Historia de la transfusión sanguínea. Rev Mex Anest. 2017; 40: 233-238.
2. Kim MJ, Park Q, Min HK, Kim HO. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010. BMC Infect Dis. 2012; 12: 160. doi: 10.1186/ 1471-2334-12-160.
3. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386 (10003): 1546-1555.
4. World Health Organization. Global hepatitis report. Geneva: World Health Organization; 2017.
5. Calleja PJ, Llop HE, Ruiz MM, De la Revilla NJ, Calvo BE, Pons RF et al. Prevalence of viral hepatitis (Band C) serological warkers in healthy working population. Rev Esp Enferm Dig. 2013; 105: 249-254.